Company news

GB Sciences, Inc. news in 2018

GB Sciences, Inc.'s news releases, calls and decks from 2018, newest first.

View company

GB Sciences Declares A "Research Revolution" At Its "2018 Innovation In Medical Cannabis Therapies" Symposium

December 14, 2018

GB Sciences and The Colorado Hemp Project Sell First Hemp Crop for $0.7 Million Dollars

December 12, 2018

Dr. Andrea Small-Howard, GB Sciences' Chief Science Officer, Introduces, "Unique Methods to Identify Strong Lead Compounds" at the International Cannabinoid Derived Pharmaceutical Summit

December 11, 2018

GB Sciences Is Maximizing the Production of Critical Medical Components from Specific Cannabis Strains

December 7, 2018

GB Sciences and Louisiana State University Agricultural Center Enter a Joint Research and Development Agreement for the Production of Therapeutic Cannabis Targeting Severe Medical Conditions and Diseases

December 7, 2018

GB Sciences Co-Authors a Peer-Reviewed Article Showing that Heart Failure Can Be Mitigated, and Reversed, by Orally Administered Drugs Targeting a Cellular Cannabinoid Receptor

November 27, 2018

GB Sciences Files First Of Its Kind Provisional Patent Application For The Treatment Of Neuropathic Pain Using Time-Released, Myrcene-Based Nanoparticles

November 20, 2018

More From Meredith Patterson, GB Sciences' Brain Nurse, As She Examines the Workings of CBD

November 14, 2018

GB Sciences Expands into the Oklahoma Medical Cannabis Market

November 14, 2018

Meredith Patterson, GB Sciences' Brain Nurse, Examines the Workings of CBD

November 6, 2018

GB Sciences Sponsors "2018 Innovation In Medical Cannabis Therapies" Symposium

November 1, 2018

GB Sciences' Brain Nurse Explores the New and Exciting World of Medical Cannabis

October 25, 2018

GB Sciences Harvests the First Hemp Crop in Colorado

October 16, 2018

GB Sciences' CEO John Poss and Chief Science Officer Dr. Andrea Small-Howard Featured at Digital Hollywood's California Cannabis Forum in Los Angeles

October 10, 2018

GB Sciences' Dr. Andrea Small-Howard Presents Results of GB Sciences' Novel Pain Formulation Research at UCLA during CannMed 2018

October 9, 2018

GB Sciences and University of Athens, Greece, Embark on Next-Level Drug Discovery Examining Cannabis-Based, Disease-Modifying Compounds

October 3, 2018

GB Sciences' Drug Development Program Benefits from Establishment of Clear Pathway for Cannabis-Based Drug Approvals and Commercialization

October 2, 2018

Catalent Selected to Provide Oral Delivery Systems for GB Sciences' Proprietary Parkinson's Disease Therapies

September 26, 2018

GB Sciences Granted a Recreational Production License for the Manufacture of Oils, Edibles, Vape Products, and Nutraceuticals

September 25, 2018

GB Sciences Hosts Cutting-Edge Cannabis Symposium "Innovation in Medical Cannabis Therapies"

September 20, 2018

GB Sciences' Dr. Andrea Small-Howard, Chief Science Officer, Will Be Moderating a Panel Discussion in "Cannabis Is Medicine" at the "State of Cannabis" Conference on the Queen Mary

September 18, 2018

The State of Louisiana Pharmacy Board Has Selected Nine Initial Pharmacies to Dispense Medical Cannabis Formulations Through the GB Sciences and LSU Agriculture Center Partnership

August 23, 2018

GB Sciences and Louisiana State University Agricultural Center Begins Cultivation of Their First Cannabis Crop

August 21, 2018

GB Sciences reports first quarter revenue of $1.3 million with gross profit of $700 thousand compared to revenue of $69,100 for same period last year

August 15, 2018

Michigan State University's Dr. Norbert Kaminski Begins Pre-Clinical Study of GB Sciences' Neuroprotective Cannabis Compounds For Parkinson's Disease

August 6, 2018

GB Sciences Co-Authors a Peer Reviewed Article Published in the Journal of the American Heart Association Titled: "Cannabinoids, The Heart of the Matter"

August 2, 2018

GB Sciences Strengthen Their Current and Future Compliance Programs by Building A Relationship with Adherence Compliance

July 31, 2018

GB Sciences Partners with the Colorado Hemp Project to Cultivate and Extract Full Spectrum Hemp Oil from Proprietary Hemp Strains to Open a New Revenue Stream in the Rapidly Growing Hemp Market

July 16, 2018

GB Sciences One of Ten Companies Named in Important New Canadian Research Publication

July 9, 2018

GB Sciences Files Patent on Cannabis-based Therapies for the Treatment of Asthma, Urinary Cystitis, Hearing Loss, plus Chronic, Inflammatory and Neuropathic Pain

June 27, 2018

GB Sciences Files Patents for Heart Disease and Chronic, Immunological, and Neuropathic Pain

June 25, 2018

GB Sciences Puts Its Grey Matter To Work Solving The Big Green Riddle...

May 23, 2018

GB Sciences Will Now Serve A Greatly Expanded Patient Base In Louisiana With The Addition Of Autism, Glaucoma, Parkinson's, PTSD, Intractable Pain And Severe Muscle Spasms To The List Of Ailments Covered By Medical Cannabis Legislation

May 22, 2018

GB Sciences' Acquisition Of NevadaPURE Is Terminated

May 9, 2018

Marijuana Stocks for Investors in the Free Cannabis Investor Magazine

May 6, 2018

GB Sciences, CEO, John Poss, Joins Everett Jolly on Uptick Newswire’s “Stock Day” Podcast

April 19, 2018

Exploratory IND Is Planned Using GB Sciences' Proprietary Mixtures of Botanical Compounds to Provide the Highest Efficacy for Patients

April 17, 2018

GB Sciences Announces the Appointment of John B. Davis as Executive VP and General Counsel

April 12, 2018

GB Sciences Pursues FDA-Registered, First-in-Human Trial of Cannabis-based Therapy for Parkinson's Disease

April 10, 2018

GB Sciences Completes Nanotechnology Transfer of Exclusively-Licensed, Cannabinoid-Based, Time-Released Neuropathic Pain Formula

April 4, 2018

GB Sciences Signs Letter of Intent to Acquire NevadaPURE's Las Vegas Operations: Gaining $16 Million in Annualized Revenues

March 28, 2018

GB Sciences Sponsors "Innovation in Medical Cannabis Therapies" Symposium

March 15, 2018

GB Sciences, Inc. Enters A New Market by Signing a Contract Farming Agreement for the Development of Boutique Hemp Genetics with the Colorado Hemp Project

February 27, 2018

GB Sciences Receives Issuance of Its Cannabis Oil Production License

February 21, 2018

GB Sciences Partners with Wellcana Group, LLC. in the Development of Medical Cannabis in Louisiana

February 14, 2018

John Poss, Chief Executive Officer of GB Sciences, Inc., Returns to Uptick Newswire’s “Stock Day” Podcast with Everett Jolly for Operational Update

February 6, 2018

GB Sciences Files a Nonprovisional Patent Application for Cannabis-Based Anti-Inflammatory Therapies Including Arthritis, Asthma, Eczema and More

February 5, 2018

GB Sciences Welcomes Dr. Zoltan Mari, A Nationally Recognized Expert on the Study and Treatment of Parkinson's Disease to Their Scientific Advisory Board

January 25, 2018

Decks in 2018